History
A list of downloadable documents created during development.
Review proposal consultation: 1
Background information
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: equality impact assessment - guidance development
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: equality impact assessment - guidance development
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: second appeal (rejected)
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: appeal from Pierre Fabre Ltd
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - appeal received
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - initial scrutiny letter
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - response to the initial scrutiny
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - final scrutiny
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appraisal determination 2
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appraisal determination 2
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final scope
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appraisal determination (March 2011)
-
-
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appeal panel decision
-
Transitional cell carcinoma of the urothelial tract - vinflunine: appeal
-
Transitional cell carcinoma of the urothelial tract - vinflunine: appeal information
-
Transitional cell carcinoma of the urothelial tract - vinflunine: appeal decision
-
Transitional cell carcinoma of the urothelial tract - vinflunine: appeal decision (PDF 154 KB)
-
Transitional cell carcinoma of the urothelial tract - vinflunine: appeal announcement information
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - appeal received
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - initial scrutiny letter
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - response to scrutiny letter
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - final scrutiny letter
-
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: notice of appeal information
Transitional cell carcinoma of the urothelial tract - vinflunine: final appraisal determination
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: final appraisal determination document
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: response to consultee, commentator and public comments on the ACD and comments from website consultation
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: consultee and commentator comments on the ACD
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre (PDF 150 KB)
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Action on Bladder Cancer
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: British Uro-oncology Group
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: joint response from NCRI/Royal College of Physicians/RCR/ACP/JCCO
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: NHS Norfolk
-
Transitional cell carcinoma of the urothelial tract - vinflunine: NHS Norfolk (PDF 30 KB)
Transitional cell carcinoma of the urothelial tract - vinflunine: appraisal consultation
-
Transitional cell carcinoma of the urothelial tract - vinflunine: appraisal consultation
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: evaluation report
-
Transitional cell carcinoma of the urothelial tract - vinflunine: pre-meeting briefing
-
Transitional cell carcinoma of the urothelial tract - vinflunine: pre-meeting briefing (PDF 158 KB)
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Evidence Review Group report
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Evidence Review Group report - factual accuracy check
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: non-manufacturer submissions
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Royal College of Pathologists
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Royal College of Physicians
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre (PDF 2.64 MB)
-
Transitional cell carcinoma of the urothelial tract - vinflunine: clarification letters
-
Transitional cell carcinoma of the urothelial tract - vinflunine: NICE request for clarification
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre response to clarification request
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: outstanding response to clarification request
-
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Birtle
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Birtle (PDF 63 KB)
Transitional cell carcinoma of the urothelial tract - vinflunine: final scope
-
Transitional cell carcinoma of the urothelial tract - vinflunine: final scope
-
Transitional cell carcinoma of the urothelial tract - vinflunine: final scope (PDF 25 KB)
Transitional cell carcinoma of the urothelial tract - vinflunine: final matrix of consultees and commentators
-
Transitional cell carcinoma of the urothelial tract - vinflunine: final matrix of consultees and commentators
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Institute's response to consultee and commentator comments on the draft scope
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Institute's response to consultee and commentator comments on the draft scope
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Institute's response to consultee and commentator comments on the provisional matrix
-
Transitional cell carcinoma of the urothelial tract - vinflunine: Institute's response to consultee and commentator comments on the provisional matrix
-